Abstract

The SARS-CoV-2 infection [coronavirus disease 2019 (COVID-19)] is associated with severe lymphopenia and impaired immune response, including expansion of myeloid cells with regulatory functions, e.g., so-called low-density neutrophils, containing granulocytic myeloid-derived suppressor cells (LDNs/PMN-MDSCs). These cells have been described in both infections and cancer and are known for their immunosuppressive activity. In the case of COVID-19, long-term complications have been frequently observed (long-COVID). In this context, we aimed to investigate the immune response of COVID-19 convalescents after a mild or asymptomatic course of disease. We enrolled 13 convalescents who underwent a mild or asymptomatic infection with SARS-CoV-2, confirmed by a positive result of the PCR test, and 13 healthy donors without SARS-CoV-2 infection in the past. Whole blood was used for T-cell subpopulation and LDNs/PMN-MDSCs analysis. LDNs/PMN-MDSCs and normal density neutrophils (NDNs) were sorted out by FACS and used for T-cell proliferation assay with autologous T cells activated with anti-CD3 mAb. Serum samples were used for the detection of anti-SARS-CoV-2 neutralizing IgG and GM-CSF concentration. Our results showed that in convalescents, even 3 months after infection, an elevated level of LDNs/PMN-MDSCs is still maintained in the blood, which correlates negatively with the level of CD8+ and double-negative T cells. Moreover, LDNs/PMN-MDSCs and NDNs showed a tendency for affecting the production of anti-SARS-CoV-2 S1 neutralizing antibodies. Surprisingly, our data showed that in addition to LDNs/PMN-MDSCs, NDNs from convalescents also inhibit proliferation of autologous T cells. Additionally, in the convalescent sera, we detected significantly higher concentrations of GM-CSF, indicating the role of emergency granulopoiesis. We conclude that in mild or asymptomatic COVID-19 convalescents, the neutrophil dysfunction, including propagation of PD-L1-positive LDNs/PMN-MDSCs and NDNs, is responsible for long-term endotype of immunosuppression.

Highlights

  • Since the beginning of 2020, the COVID-19 pandemic has affected more than 200 million people worldwide, causing over 4.5 million deaths so far

  • Searching for the reason of suppression induced by neutrophil subsets from COVID–19 convalescents, we looked at the PD–L1 expression as a key marker related with such an activity and found that both populations of low–density neutrophils (LDNs)/PMN–myeloid-derived suppressor cells (MDSCs) and normal density neutrophils (NDNs) showed high expression of immunosuppressive PD– L1 (Figure 3B)

  • Our data suggest that propagation of LDNs/PMN– MDSCs and presence of NDNs with regulatory functions are responsible for long–term endotype of immunosuppression in this group

Read more

Summary

Introduction

Since the beginning of 2020, the COVID-19 pandemic has affected more than 200 million people worldwide, causing over 4.5 million deaths so far. Lymphopenia has been reported concurrently with onset of the clinical symptoms [6] In this context, an alternative hypothesis claims the collapse of the host protective immunity (“immunologic collapse”), leading to failure in control of viral replication and dissemination [11,12,13,14]. An alternative hypothesis claims the collapse of the host protective immunity (“immunologic collapse”), leading to failure in control of viral replication and dissemination [11,12,13,14] In this scenario, an increased production of prostaglandin D2 by the respiratory epithelium [15] causes inhibition of the dendritic cell response via DP1 receptor signaling and/or upregulation of myeloid cells with regulatory functions, including myeloid-derived suppressor cells (MDSCs), which may be one of the mechanisms attenuating inflammatory response [16, 17]. The early expansion of MDSCs may inhibit SARS-CoV-2 antigenspecific T-cell response and predict fatal outcome [18], suggesting these cells as important players during COVID-19

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call